Latest AGIO reports update at 2024-05-02: 2024-Q12023-Q42023-Q1
Agios Pharmaceuticals logo
Agios Pharmaceuticals AGIO
$ 32.92 1.42%

Agios Pharmaceuticals Financial Ratios 2011-2024 | AGIO

Annual Financial Ratios Agios Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.2 -6.1 1.2 -9.1 -7.6 -8.6 -11.9 -8.0 -13.4 -72.9 -11.1 - -

P/S

55.6 99.6 - 14.7 26.5 31.4 87.3 22.7 26.7 59.7 17.1 - -

EPS

-6.3 -4.2 26.6 -4.7 -6.9 -6.0 -6.8 -5.1 -3.1 -1.6 -2.8 -8.0 -8.9

EV (Enterprise Value)

1.53 B 1.42 B 1.93 B 3.32 B 3.29 B 3.06 B 3.89 B 1.68 B 1.58 B 3.96 B 435 M 1.81 M 13.7 M

EBITDA per Share

-6.92 -6.95 -6.11 -4.73 -6.97 -6.19 -6.75 -4.99 -3.08 -1.57 -2.43 - -

EV/EBITDA

-5.1 -10.2 -7.3 -8.1 -11.6 -7.3 -13.1 -73.7 -9.8 - -

PEG

-0.92 -2.02 0.17 -0.66 0.55 -0.8 0.36 0.13 0.14 -1.66 0.08 - -

P/B

1.8 1.3 1.5 7.5 4.9 4.3 10.0 4.4 4.6 9.2 3.3 - -

P/CF

-5.0 -4.6 -4.9 -10.3 -8.2 -9.5 -13.0 55.3 -16.3 -63.4 -7.6 - -

ROE %

-43.41 -21.06 124.21 -81.94 -64.24 -50.33 -83.80 -55.35 -34.11 -12.61 -29.97 - -

ROA %

-37.57 -18.71 111.61 -38.38 -46.19 -40.31 -51.22 -32.06 -28.03 -10.88 -19.59 - -

ROCE %

-48.27 -35.34 -29.29 -84.08 -53.43 -47.39 -61.76 -37.87 -32.33 -12.57 -23.67 - -

Current Ratio

7.4 9.0 9.9 1.9 6.6 6.6 4.7 6.3 6.4 5.9 4.6 - -

DSO

- - - - 47.4 40.4 32.6 43.4 71.6 70.7 6.8 - -

DIO

1746.3 909.5 - 477.0 2031.8 227.0 - - - - - - -

DPO

1798.8 3782.4 - 3171.1 6068.4 4671.6 - - - - - - -

Operating Cycle

1746.3 909.5 - 477.0 2079.2 267.4 - - - - - - -

Cash Conversion Cycle

-52.5 -2872.9 - -2694.2 -3989.2 -4404.2 - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Agios Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.45 - -1.64 -1.51 -1.47 - -1.49 -1.68 -1.74 -1.74 -1.56 -1.41 26.95 -1.41 -1.43 -1.31 -0.59 -1.6 -1.81 -1.87 -1.59 -1.58 -1.63 -1.19 -1.63 -1.81 -1.59 -1.78 -1.56 -1.34 -1.63 -1.47 -0.61 -1.08 -1.07 -0.85 -0.13 -0.76 0.11 -0.54 -0.39 -0.4 -0.52 -2.8 -2.47 -2.09 -0.83 -2.18 -1.98 - - - -

EBITDA per Share

- - - - - - -1.66 -1.78 -1.85 - -1.6 -1.49 -1.31 -1.33 -1.16 -1.21 -1.23 -1.55 -1.85 -1.87 -1.63 -1.66 -1.62 -1.2 -1.66 -1.85 -1.53 -1.74 -1.55 -1.36 -1.54 -1.42 -0.59 -1.08 -1.02 -0.83 -0.13 -0.72 0.12 -0.53 -0.38 -0.39 -0.44 -2.1 -1.83 -1.8 -1.24 -1.66 - - - - -

ROE %

-40.25 -26.81 -34.59 -32.08 -31.55 -23.80 -31.12 -29.70 -26.54 62.92 45.80 27.38 9.74 -81.94 -73.48 -65.28 -59.78 -64.24 -61.61 -58.80 -51.65 -50.33 -60.49 -67.26 -79.39 -83.80 -66.76 -63.74 -57.22 -46.06 -51.37 -45.51 -39.15 -34.11 -28.63 -16.09 -11.16 -12.61 -15.74 -25.12 -27.36 -29.97 -13.18 1.77 15.98 21.48 14.10 7.65 - - - - -

ROA %

-35.45 -23.83 -30.75 -28.61 -27.98 -21.12 -27.70 -19.43 -24.03 58.38 53.51 47.67 41.66 -38.38 -38.42 -38.74 -40.46 -46.19 -45.40 -44.50 -40.18 -40.31 -43.98 -45.51 -51.03 -51.22 -40.59 -38.19 -33.70 -26.68 -32.60 -32.04 -30.59 -28.03 -23.78 -13.44 -9.57 -10.88 -11.61 -17.92 -18.48 -19.59 -17.31 -15.14 -14.88 -11.29 -7.41 -4.02 - - - - -

ROCE %

-44.85 -29.84 -38.51 -35.81 -34.78 -25.74 -32.27 -30.13 -26.75 -15.81 -38.94 -52.50 -68.05 -85.86 -79.26 -76.19 -73.13 -66.56 -64.04 -61.43 -54.27 -52.72 -62.71 -69.33 -81.25 -85.43 -77.44 -74.11 -67.32 -56.05 -51.89 -45.91 -39.47 -34.39 -28.84 -16.36 -11.37 -12.76 -15.77 -24.94 -27.11 -29.57 -11.24 4.27 19.26 24.62 15.60 8.50 - - - - -

Current Ratio

8.0 7.4 8.4 9.0 10.0 9.0 9.1 - 10.4 9.9 10.5 12.3 13.0 1.9 1.9 1.9 1.9 3.6 3.6 3.6 3.6 5.0 5.0 5.0 5.0 2.6 2.6 2.6 2.6 2.4 2.4 2.4 - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - 240.1 - - - - - - - - - - - - - - - 0.9 4.8 6.6 17.0 29.9 13.8 34.8 44.8 9.9 49.5 56.2 23.3 7.6 14.6 6.3 25.3 12.7 - - - - - - - - - - - -

DIO

3066.8 - 2374.6 1113.7 1636.1 - 456.8 260.6 334.4 - - - - - 1616.3 1420.0 1464.5 - 1702.2 2207.8 1120.1 - 114.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

1523.4 - 1794.5 835.4 2246.5 - 919.1 1211.5 3802.2 - - - - - 2535.0 2396.0 3391.5 - 5084.0 6594.1 5433.5 - 2347.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

3066.8 - 2374.6 1113.7 1636.1 - 456.8 260.6 574.5 - - - - - 1616.3 1420.0 1464.5 - 1702.2 2207.8 1120.1 - 114.1 - 0.9 4.8 6.6 17.0 29.9 13.8 34.8 44.8 9.9 49.5 56.2 23.3 7.6 14.6 6.3 25.3 12.7 - - - - - - - - - - - -

Cash Conversion Cycle

1543.5 - 580.1 278.2 -610.4 - -462.3 -950.9 -3227.7 - - - - - -918.6 -976.0 -1927.0 - -3381.8 -4386.3 -4313.3 - -2233.4 - 0.9 4.8 6.6 17.0 29.9 13.8 34.8 44.8 9.9 49.5 56.2 23.3 7.6 14.6 6.3 25.3 12.7 - - - - - - - - - - - -

All numbers in USD currency